1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Yu J, Tao Q, Cheung KF, Jin H, Poon FF,
Wang X, Li H, Cheng YY, Röcken C, Ebert MP, et al: Epigenetic
identification of ubiquitin carboxyl-terminal hydrolase L1 as a
functional tumor suppressor and biomarker for hepatocellular
carcinoma and other digestive tumors. Hepatology. 48:508–518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
3
|
You Y, Ma Y, Wang Q, Ye Z, Deng Y and Bai
F: Attenuated ZHX3 expression serves as a potential biomarker that
predicts poor clinical outcomes in breast cancer patients. Cancer
Manag Res. 11:1199–1210. 2019. View Article : Google Scholar : PubMed/NCBI
|
4
|
You Y, Bai F, Li H, Ma Y, Yao L, Hu J and
Tian Y: Prognostic value and therapeutic implications of ZHX family
member expression in human gastric cancer. Am J Transl Res.
12:3376–3388. 2020.PubMed/NCBI
|
5
|
Liu Y, Ma D and Ji C: Zinc fingers and
homeoboxes family in human diseases. Cancer Gene Ther. 22:223–226.
2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Barthelemy I, Carramolino L, Gutiérrez J,
Barbero JL, Márquez G and Zaballos A: A novel mouse homeodomain
protein containing two zinc-fingers and five homeodomains. Biochem
Biophys Res Commun. 224:870–876. 1996. View Article : Google Scholar : PubMed/NCBI
|
7
|
Hirano S, Yamada K, Kawata H, Shou Z,
Mizutani T, Yazawa T, Kajitani T, Sekiguchi T, Yoshino M,
Shigematsu Y, et al: Rat zinc-fingers and homeoboxes 1 (ZHX1), a
nuclear factor-YA-interacting nuclear protein, forms a homodimer.
Gene. 290:107–114. 2002. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kawata H, Yamada K, Shou Z, Mizutani T,
Yazawa T, Yoshino M, Sekiguchi T, Kajitani T and Miyamoto K:
Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX
family, functions as a transcriptional repressor. Biochem J.
373:747–757. 2003. View Article : Google Scholar : PubMed/NCBI
|
9
|
Yamada K, Kawata H, Shou Z, Hirano S,
Mizutani T, Yazawa T, Sekiguchi T, Yoshino M, Kajitani T and
Miyamoto K: Analysis of zinc-fingers and homeoboxes
(ZHX)-1-interacting proteins: Molecular cloning and
characterization of a member of the ZHX family, ZHX3. Biochem J.
373:167–178. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kawata H, Yamada K, Shou Z, Mizutani T and
Miyamoto K: The mouse zinc-fingers and homeoboxes (ZHX) family;
ZHX2 forms a heterodimer with ZHX3. Gene. 323:133–140. 2003.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Suehiro F, Nishimura M, Kawamoto T, Kanawa
M, Yoshizawa Y, Murata H and Kato Y: Impact of zinc fingers and
homeoboxes 3 on the regulation of mesenchymal stem cell osteogenic
differentiation. Stem Cells Dev. 20:1539–1547. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Liu G, Clement LC, Kanwar YS, Avila-Casado
C and Chugh SS: ZHX proteins regulate podocyte gene expression
during the development of nephrotic syndrome. J Biol Chem.
281:39681–39692. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Clement LC, Liu G, Perez-Torres I, Kanwar
YS, Avila-Casado C and Chugh SS: Early changes in gene expression
that influence the course of primary glomerular disease. Kidney
Int. 72:337–347. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Nagel S, Ehrentraut S, Meyer C, Kaufmann
M, Drexler HG and MacLeod RA: Aberrantly expressed OTX homeobox
genes deregulate B-cell differentiation in hodgkin lymphoma. PLoS
One. 10:e01384162015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
16
|
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu
JS, Li B and Liu XS: TIMER: A web server for comprehensive analysis
of tumor-infiltrating immune cells. Cancer Res. 77:e108–e110. 2017.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Barretina J, Caponigro G, Stransky N,
Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV,
Sonkin D, et al: The cancer cell line encyclopedia enables
predictive modelling of anticancerdrug sensitivity. Nature.
483:603–607. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lanczky A, Nagy A, Bottai G, Munkacsy G,
Szabo A, Santarpia L and Gyorffy B: miRpower: A web-tool to
validate survival-associated miRNAs utilizing expression data from
2,178 breast cancer patients. Breast Cancer Res Treat. 160:439–446.
2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Szász AM, Lánczky A, Nagy Á, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
20
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
You Y, Li H, Qin X, Zhang Y, Song W, Ran Y
and Gao F: Decreased CDK10 expression correlates with lymph node
metastasis and predicts poor outcome in breast cancer patients - a
short report. Cell Oncol (Dordr). 38:485–491. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
You Y, Li H, Qin X, Ran Y and Wang F.:
Down-regulated ECRG4 expression in breast cancer and its
correlation with tumor progression and poor prognosis-A short
report. Cell Oncol (Dordr). 39:89–95. 2016. View Article : Google Scholar : PubMed/NCBI
|
24
|
Wang J, Liu D, Liang X, Gao L, Yue X, Yang
Y, Ma C and Liu J: Construction of a recombinant eukaryotic human
ZHX1 gene expression plasmid and the role of ZHX1 in hepatocellular
carcinoma. Mol Med Rep. 8:1531–1536. 2013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wang Z, Ma X, Cai Q, Wang X, Yu B, Cai Q,
liu B, Zhu Z and Li C: MiR-199a-3p promotes gastric cancer
progression by targeting ZHX1. FEBS Lett. 588:4504–4512. 2014.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Ma X, Huang M, Wang Z, Liu B, Zhu Z and Li
C: ZHX1 inhibits gastric cancer cell growth through inducing
cell-cycle arrest and apoptosis. J Cancer. 7:60–68. 2016.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Kwon RJ, Kim YH, Jeong DC, Han ME, Kim JY,
Liu L, Jung JS and Oh SO: Expression and prognostic significance of
zinc fingers and homeoboxes family members in renal cell carcinoma.
PLoS One. 12:e01710362017. View Article : Google Scholar : PubMed/NCBI
|
28
|
Guan J, Liu Z, Xiao M, Hao F, Wang C, Chen
Y, Lu Y and Liang J: MicroRNA-199a-3p inhibits tumorigenesis of
hepatocellular carcinoma cells by targeting ZHX1/PUMA signal. Am J
Transl Res. 9:2457–2465. 2017.PubMed/NCBI
|
29
|
Kwon RJ, Han ME, Kim JY, Liu L, Kim YH,
Jung JS and Oh SO: ZHX1 promotes the proliferation, migration and
invasion of cholangiocarcinoma cells. PLoS One. 11:e01655162016.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Kwon RJ, Han ME, Kim YJ, Kim YH, Kim JY,
Liu L, Heo W and Oh SO: Roles of zinc-fingers and homeoboxes 1
during the proliferation, migration, and invasion of glioblastoma
cells. Tumour Biol. 39:10104283176945752017. View Article : Google Scholar : PubMed/NCBI
|
31
|
Yamada K, Ogata-Kawata H, Matsuura K,
Kagawa N, Takagi K, Asano K, Haneishi A and Miyamoto K: ZHX2 and
ZHX3 repress cancer markers in normal hepatocytes. Front Biosci
(Landmark Ed). 14:3724–3732. 2009. View
Article : Google Scholar : PubMed/NCBI
|
32
|
Lv Z, Zhang M, Bi J, Xu F, Hu S and Wen J:
Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular
carcinoma. Am J Clin Pathol. 125:740–746. 2006. View Article : Google Scholar : PubMed/NCBI
|
33
|
Yue X, Zhang Z, Liang X, Gao L, Zhang X,
Zhao D, Liu X, Ma H, Guo M, Spear BT, et al: Zinc fingers and
homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation
and represses expression of cyclins A and E. Gastroenterology.
142:1559–1570.e2. 2012. View Article : Google Scholar : PubMed/NCBI
|
34
|
Luan F, Liu P, Ma H, Yue X, Liu J, Gao L,
Liang X and Ma C: Reduced nucleic ZHX2 involves in oncogenic
activation of glypican 3 in human hepatocellular carcinoma. Int J
Biochem Cell Biol. 55:129–135. 2014. View Article : Google Scholar : PubMed/NCBI
|
35
|
Song X, Tan S, Wu Z, Xu L, Wang Z, Xu Y,
Wang T, Gao C, Gong Y, Liang X, et al: HBV suppresses ZHX2
expression to promote proliferation of HCC through miR-155
activation. Int J Cancer. 143:3120–3130. 2018. View Article : Google Scholar : PubMed/NCBI
|
36
|
Xu L, Wu Z, Tan S, Wang Z, Lin Q, Li X,
Song X, Liu Y, Song Y, Zhang J, et al: Tumor suppressor ZHX2
restricts hepatitis B virus replication via epigenetic and
non-epigenetic manners. Antiviral Res. 153:114–123. 2018.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Hu S, Zhang M, Lv Z, Bi J, Dong Y and Wen
J: Expression of zinc-fingers and homeoboxes 2 in hepatocellular
carcinogenesis: A tissue microarray and clinicopathological
analysis. Neoplasma. 54:207–211. 2007.PubMed/NCBI
|
38
|
Armellini A, Sarasquete ME, García-Sanz R,
Chillón MC, Balanzategui A, Alcoceba M, Fuertes M, López R,
Hernández JM, Fernández-Calvo J, et al: Low expression of ZHX2, but
not RCBTB2 or RAN, is associated with poor outcome in multiple
myeloma. Br J Haematol. 141:212–215. 2008. View Article : Google Scholar : PubMed/NCBI
|